Imbruvica (ibrutinib) - AbbVie, J&J
Venclexta (venetoclax) - Roche, AbbVie
AS-1763 - Carna Biosci
Jaypirca (pirtobrutinib) - Eli Lilly
https://library.ehaweb.org/eha/2024/eha2024-congress/420717/nitin.jain.preliminary.safety.and.efficacy.results.from.a.phase.1b.study.of.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Ace_id%3D2552%2Aot_id%3D29194%2Amarker%3D5101%2Afeatured%3D18527
 
Nitin Jain; Catherine C. Coombs; James D'Olimpio; Nirav N Shah; Jacqueline Barrientos; Seung Tae Lee; Andrew Gillis-Smith; Shuo Ma; Shirou Kirita; Masaaki Sawa; Kyoko Miyamoto; Akinori Arimura; William Wierda; Varsha Gandhi; Javier Pinilla-Ibarz
 
May 15, 2024
 
Next